I don't know when transition happened where we, to me, we're big kids and we're animals in nice suits
Advanced beta-cell dysfunction represents a significant physiological barrier to tirzepatide efficacy
Each patient begins with comprehensive lab work and a provider consultation to determine the safest and most effective treatment
Foundation said on Tuesday that it has selected Professor Joel Habenner of Massachusetts General Hospital, Chief Scientific Adviser Rothe Knussen Novo Nordisk, and Professor Svetlana Moszov of Rockefeller University as this year's winners
Real-world observations suggest that properly dosed sublingual semaglutide at therapeutic levels can produce meaningful weight loss, typically in the range of 8% to 15% body weight over 12 to 16 weeks
Co ntent Disclaimer: The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthesiology